SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: David Cathcart who wrote (712)2/19/1998 6:49:00 PM
From: Glenn W  Respond to of 1826
 
<< My short-term goal is to make Adam happy.>>

I think it would be nice if we made Adam ecstatic........

Glenn



To: David Cathcart who wrote (712)2/19/1998 9:14:00 PM
From: the eagle  Read Replies (2) | Respond to of 1826
 
since i know little about the technical aspects of mgi 114 could someone give us some perspective on this new drug. are we saying the tumors this drug will try to reduce are the type that this drug has been unable to reduce. i guess what i am asking is for someone to give all of us some realistic view of what the prospects are for this drug based on data available in layman's terms.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News